Country: Singapura
Bahasa: Inggeris
Sumber: HSA (Health Sciences Authority)
SIEMENS HEALTHCARE PTE. LTD.
Class B IVD
Siemens Healthcare Diagnostics Products GmbH
Clinical chemistry
N APOAII is an in vitro diagnostic reagent for the quantitative IFCC-standardized determination of apolipoprotein A-II (Apo A-II) as an aid in the assessment of high-density lipoprotein (HDL) metabolism defects related to cardiovascular disease and arteriosclerosis in human serum by means of automated Siemens Healthineers immuno- nephelometry systems. N APOE is an in vitro diagnostic reagent for the quantitative determination of apolipoprotein E (Apo E) in human serum as an aid to diagnosis for congenital hyperlipoproteinemia by means of automated Siemens Healthineers immuno-nephelometry systems.
Models: N Apolipoprotein A-II Kit - OQBA09, N Apolipoprotein E Kit - OQDL09, N Apolipoprotein Standard Serum - OUPG07, Apolipoprotein Control Serum CHD (human) - OUPH07, BN ProSpec System AP Update 3.0 CD Kit OUS - 10987487, N Reaction Buffer - OUMS61, N Reaction Buffer - OUMS65, N Diluent - OUMT05, BN ProSpec System - OVLI01, BN II System - OVIA11 (10801162), Atellica NEPH 630 System - OVLI02 (11239861)
2016-07-20